LGND — LIGAND PHARMACEUTICALS INC

Ownership history in Squarepoint Ops LLC  ·  23 quarters on record

This page tracks every 13F SEC filing in which Squarepoint Ops LLC reported a position in LIGAND PHARMACEUTICALS INC (LGND). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.21% (2015 Q2)
Avg. % of fund
0.02%
First filed
2015 Q2
Last filed
2025 Q3
Quarters held
23
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 17,897 +14,403 +412.2% 0.00% $3.2M $177.14
2025 Q1 REDUCED 3,494 -13,305 -79.2% 0.00% $367K $105.14
2024 Q4 ADDED 16,799 +13,741 +449.3% 0.00% $1.8M $107.15
2022 Q4 REDUCED 3,058 -8,775 -74.2% 0.00% $204K $66.80
19 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    LGND price (monthly, adj. close)

Other funds also holding LGND

As of 2025 Q4 — sorted by position size

ASHFORD CAPITAL MANAGEMENT INC 3Y 7Y 4.5% VILLERE ST DENIS J & CO LLC 3Y 7Y 3.84% Private Capital Management, LLC 3Y 7Y 3.62% Ranger Investment Management, L.P. 3Y 7Y 3.5% RICE HALL JAMES & ASSOCIATES, LLC 3Y 7Y 2.91% Chicago Capital, LLC 3Y 7Y 2.62% Uniplan Investment Counsel, Inc. 3Y 7Y 2.15% Lisanti Capital Growth, LLC 3Y 7Y 1.96% ESSEX INVESTMENT MANAGEMENT CO LLC 3Y 7Y 1.73% Penn Capital Management Company, LLC 3Y 7Y 1.49%
← Back to Squarepoint Ops LLC Holdings